Old Web
English
Sign In
Acemap
>
authorDetail
>
Rosa Fida
Rosa Fida
Pharmacology
Von Willebrand factor
Phases of clinical research
Pharmacodynamics
Dosing
2
Papers
40
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent
2013
Investigational New Drugs
Matthew Burge
Alessandra Francesconi
Dusan Kotasek
Rosa Fida
Gregg Smith
Andrew F. Wilks
P. Vasey
Jason Lickliter
Show All
Source
Cite
Save
Citations (14)
CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo
2009
Molecular Cancer Therapeutics
Christopher J. Burns
Emmanuelle Fantino
Ian D Phillips
Stephen Su
Michael Francis Harte
Patricia Evelina Bukczynska
Mark Frazzetto
Max Joffe
Irma Kruszelnicki
Bing Wang
Yue Wang
Neil Wilson
Rodney J. Dilley
Soo San Wan
Susan A. Charman
David M. Shackleford
Rosa Fida
Cathy Malcontenti-Wilson
Andrew F. Wilks
Show All
Source
Cite
Save
Citations (26)
1